RxDoctor Payments Data

Rachel Bonner

Family · Leesburg, VANPI 1144255084

Payments from drug & device makers

$938in general payments, 2019–2025

Across 52 payments — averaging $18.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$231
  • AbbVie$204
  • Takeda Pharmaceuticals U.S.A., Inc.$78
  • Lilly USA, LLC$56
  • Boehringer Ingelheim$47
  • AstraZeneca$41
  • plus $281 from 15 others

What the payments were for

  • Food & beverage$92599%
  • Education$121%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$938 in reported general payments places this provider in the 70th percentile of 4,332 family providers in Virginia.

See all family providers in Virginia

Most prescribed under Part D

DrugClaimsCost to plans & patients
ProgesteroneProgesterone, Micronized11$855
Hydroxyzine Hcl11$100

Paid to pharmacies, not to this prescriber.

Other family in Leesburg

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →